Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,708 | 86,473 | 114,623 | 141,219 | 164,660 |
| TOTAL | $86,830 | $86,518 | $115,024 | $141,655 | $165,035 |
| Non-Current Assets | |||||
| PPE Net | 461 | 284 | 315 | 83 | 74 |
| Other Non-Current Assets | 1,269 | 983 | 1,259 | 1,527 | 1,794 |
| TOTAL | $1,730 | $1,267 | $1,574 | $1,610 | $1,868 |
| Total Assets | $88,560 | $87,785 | $116,599 | $143,265 | $166,904 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,595 | 13,149 | 13,382 | 11,612 | 14,622 |
| Accrued Expenses | 10,987 | 9,295 | 10,445 | 10,163 | 5,865 |
| TOTAL | $24,550 | $23,065 | $24,707 | $22,864 | $21,683 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,313 | 49,090 | 49,174 | 48,883 | 48,598 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 82 | 330 |
| TOTAL | $49,313 | $49,090 | $49,174 | $48,965 | $48,928 |
| Total Liabilities | $73,862 | $72,155 | $73,881 | $71,828 | $70,611 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,914 | 38,477 | 37,692 | 37,682 | 37,570 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -448,831 | -409,199 | -375,223 | -340,340 | -308,056 |
| TOTAL | $14,698 | $15,630 | $42,718 | $71,437 | $96,293 |
| Total Liabilities And Equity | $88,560 | $87,785 | $116,599 | $143,265 | $166,904 |